Between September 2022 and January 2023, there were Ebola virus disease (EVD) outbreaks in Uganda with epicentres in Mubende and Kassanda districts. The World Health Organization recommends mass drug administration (MDA) for malaria in EVD outbreak settings in anticipation of disruptions to routine malaria services. In December 2022, one round of MDA using dihydroartemisinin piperaquine (DP) was implemented, targeting people three months and older. Trained village health teams distributed DP through a door-to-door approach.
This poster was presented at the Multilateral Initiative on Malaria (MIM) Society's 8th Pan-African Malaria Conference.
« Back to Publications